Title:
GZIPポリヌクレオチドおよびポリペプチドならびにその使用
Document Type and Number:
Japanese Patent JP4423038
Kind Code:
B2
Abstract:
The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GZIP polypeptides have been identified that are believed to be beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
Inventors:
Shmakov, Ilya
Gerasimenco, Oksana
Gerasimenco, Oksana
Application Number:
JP2003551302A
Publication Date:
March 03, 2010
Filing Date:
October 03, 2002
Export Citation:
Assignee:
Serono Genetics Institute Society Anonym
International Classes:
C12N15/09; A61K38/00; A61P3/04; A61P3/06; A61P3/10; A61P9/10; A61P9/12; C07K14/435; C07K14/47; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/12; G01N33/15; G01N33/50; A61K9/00; A61K9/48; A61K48/00
Foreign References:
| WO1999062939A1 |
Other References:
Biochem. Biophys. Res. Commun. (1991) vol.177, no.2, p.696-703
Cancer Res. (1998) vol.58, no.11, p.2353-2358
Cancer Res. (1998) vol.58, no.11, p.2353-2358
Attorney, Agent or Firm:
Yukio Ono